$MYOV $PFE πŸ“° Myovant Sciences and Pfizer Announce First Participant Dosed in Phase 3 SERENE Study Evaluating Contraceptive Efficacy of Once-Daily Relugolix Combination Tablet

https://quantisnow.com/insight/606413?s=s

#majorpharmaceuticals #healthcare

#digitalidentity for #healthcare is a hot topic, with@Mastercard and@icanbwell partnering on patient ID, a region… https://t.co/n5KXTHqf5J

$ATNF πŸ“œ SEC Form 4: Marc Feldmann was granted 20,910 units of Common Stock, increasing direct ownership by 0.81% to 2,617,758 units

https://quantisnow.com/insight/604824?s=s

#majorpharmaceuticals #healthcare

$ATNF πŸ“œ SEC Form 4: B. Jonathan Rothbard was granted 24,307 units of Common Stock, increasing direct ownership by 5% to 560,449 units

https://quantisnow.com/insight/604815?s=s

#majorpharmaceuticals #healthcare

$AFMD πŸ“° Affimed Announces Presentation at AACR Highlighting Initial Data from Phase 1 Study of Cord Blood-derived Natural Killer Cells Pre-complexed with Innate Cell Engager AFM13

https://quantisnow.com/insight/602926?s=s

#majorpharmaceuticals #healthcare

$ATNF πŸ“œ SEC Form 4: Lawrence Steinman was granted 22,585 units of Common Stock, increasing direct ownership by 4% to 592,358 units

https://quantisnow.com/insight/599421?s=s

#majorpharmaceuticals #healthcare

$BIIB πŸ“ƒ Biogen and Bio-Thera Solutions Announce Commercialization and License Agreement for Proposed Biosimilar Currently in Phase 3 With the Potential to Treat Moderate to Severe Rheumatoid Arthritis Biogen Inc.

https://quantisnow.com/insight/599088?s=s

#healthcare

$AFMD πŸ“ƒ Affimed to Report Full Year 2020 Financial Results &; Corporate Update on April 15, 2021

https://quantisnow.com/insight/598923?s=s

#majorpharmaceuticals #healthcare

Nothing found!

Sorry, but we could not find anything in our database for your search query {{search_query}}. Please try again by typing other keywords.